NCT00437983View on ClinicalTrials.gov

The Efficacy of Phosphatidylserine-Omega3 in Elderly With Age Associated Memory Impairment

PHASE4CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

September 30, 2008

Conditions
Age Associated Memory Impairment
Interventions
DIETARY_SUPPLEMENT

PS-Omega3

Phosphatidylserine-Omega3 capsules 3x100mg/day 15 wk. Next, follow up phase, open label,1x100mg/day, 15 wk

DIETARY_SUPPLEMENT

Placebo

Placebo cellulose tainted with fishy odor capsules 3x100mg/day 15 wk

Trial Locations (1)

64239

The Tel Aviv Sourasky Medical Center, Neurology department, Tel Aviv

Sponsors

Lead Sponsor

Enzymotec
All Listed Sponsors
lead

Enzymotec

INDUSTRY

NCT00437983 - The Efficacy of Phosphatidylserine-Omega3 in Elderly With Age Associated Memory Impairment | Biotech Hunter | Biotech Hunter